DINYA DNA, Inc.
Biotechnology · OAKLAND, CA
BiotechnologySEC Form D
DINYA DNA, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 22, 2026, reporting $3,772,104 raised toward a $4,297,104 offering.
Incorporated in Delaware and based in OAKLAND, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that DINYA DNA, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Benjamin LermanExecutive Officer · Director
- Eirik Adim MorebExecutive Officer · Director
- Andrew FelbingerDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$19.1MRaised
Rapalogix Health, Inc.
$150.0KRaised
Chickadee Biomedicines, Inc.
$500.0KRaised
Boston Interactome, Inc.
$6.5MRaised
REGENTIS BIOMATERIALS LTD.
$16.5MRaised